BIAF bioAffinity Technologies, Inc.

NASDAQ

$5.64

bioAffinity Technologies, Inc. (BIAF) Earnings News

Earnings press releases, previews and reviews for bioAffinity Technologies, Inc. (BIAF), newest first.

Friday August 7, 2026 8:00 AM ET

bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung

Friday May 8, 2026 8:30 AM ET

bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung